Press Releases

EIN Presswire

The global single-cell protein market is set to grow from US$12.1Bn in 2026 to US$21.4Bn by 2033, expanding at a steady CAGR of 8.4% driven by demands LONDON, ENGLAND, UNITED KINGDOM, July 2, 2026 /⁨EINPresswire.com⁩/ -- The global single-cell...

GlobeNewswire, Inc.

New results from HMB-002 first-in-human data validate proof of mechanism in Von Willebrand disease (VWD), elevating Von Willebrand Factor (VWF) and Factor VIII (FVIII) levels with subcutaneous dosing; multiple dose assessment underway New program...

GlobeNewswire, Inc.

LARGO, FL, June 28, 2026 (GLOBE NEWSWIRE) -- JellyFil, a company established in 2026, today announced its entry into the men's wellness supplement category with the introduction of its first product, JellyFil. The launch marks the company's...

EIN Presswire

Fishmeal Market is projected to reach USD 12.078 billion by 2034 from USD 8.185 billion in 2025, expanding at a 4.0% CAGR through 2034. PUNE, MAHARASHTRA, INDIA, August 27, 2026 /⁨EINPresswire.com⁩/ -- Fishmeal Market is entering 2026 under a very...

GlobeNewswire, Inc.

AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- ESO Solutions, Inc. (“ESO”), a leading data services and software provider for EMS, fire departments, hospitals, and government agencies, today announced the launch of ESO Prehospital Intelligence™,...

GlobeNewswire, Inc.

LAKELAND, FL, June 23, 2026 (GLOBE NEWSWIRE) -- JellyFil, a newly established company in the men's wellness sector, today announced the launch of JellyFil, a dietary supplement formulated to support men's energy, stamina, libido, and overall...

GlobeNewswire, Inc.

Company announcement – No. 27 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, June 22, 2026 – Zealand Pharma A/S...

GlobeNewswire, Inc.

Company announcement No. 26 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 25, 2026) Copenhagen, Denmark, June 22, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...

GlobeNewswire, Inc.

COPENHAGEN, Denmark, June 19, 2026 (GLOBE NEWSWIRE) -- The Novo Nordisk Foundation is funding a new pan-European initiative to accelerate drug discovery and the development of next generation therapeutics for cardiometabolic diseases (CMDs). The...

GlobeNewswire, Inc.

Pharmaceutical executive and physician with strong experience in global research and development Over 20 years’ experience in all stages of clinical development across multiple indications, including neurology and psychiatry programs Appointment...

GlobeNewswire, Inc.

Delray Beach, FL, Aug. 24, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global endoscopy equipment market will grow from USD 37.09 billion in 2025 to USD 53.54 billion by 2030, at a CAGR of 7.6% during the forecast period.

GlobeNewswire, Inc.

COPENHAGEN, Denmark, August 20, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, provides business update and announces second quarter 2026...

EIN Presswire

Non-Alcoholic Beer Market is segmented by product type, distribution channel, packaging, flavor profile, and region.

GlobeNewswire, Inc.

Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data from its Phase 2a SYNAPSE-CMT...

GlobeNewswire, Inc.

COPENHAGEN, Denmark, August 21, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the second quarter and first half of 2026 and released its financial calendar for 2027. Financial...

GlobeNewswire, Inc.

Company announcement No. 25 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 24, 2026) Copenhagen, Denmark, June 15, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...

GlobeNewswire, Inc.

New York, USA, June 15, 2026 (GLOBE NEWSWIRE) -- Osteoarthritis Market Expected to Showcase Moderate Growth at a CAGR of 3% During the Forecast Period (2026–2036) Driven by Emerging Therapies and Rising Disease Burden | DelveInsight The...

GlobeNewswire, Inc.

COPENHAGEN, Denmark, June 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, has been awarded the 2026 Prix Galien UK Award for Best digital...

GlobeNewswire, Inc.

ROTTERDAM, The Netherlands, June 17, 2026 (GLOBE NEWSWIRE) -- Univar Solutions B.V., a subsidiary of Univar Solutions LLC (“Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals,...

GlobeNewswire, Inc.

NEW YORK and LONDON and STOCKHOLM and DUBAI, United Arab Emirates and MUMBAI, India, June 15, 2026 (GLOBE NEWSWIRE) -- KingsRock Advisors, LLC, an independent global advisory firm, announced today the continuation of its growth, with a series of...